Enzyme vs Nibiru Chain — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Nibiru Chain trades at Rp35.29 (market cap Rp55,17M, Rp4,69M 24h volume). The key difference: Enzyme is far larger — about 2.4× Nibiru Chain's market cap, and Nibiru Chain's supply is capped (954M / 1,5B NIBI (64%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Nibiru Chain for 7 Days on average.
| MLN | NIBI | |
|---|---|---|
Market Cap | Rp134,13M | Rp55,17M |
Volume (24h) | Rp104,56M | Rp4,69M |
Circulating Supply | 3,3M MLN | 954M / 1,5B NIBI (64%) |
Typical Hold Time | 29 Days | 7 Days |
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Nibiru Chain is a groundbreaking Layer 1 blockchain and smart contract ecosystem that offers exceptional throughput and unmatched security. Nibiru strives to be the most developer-friendly and user-friendly smart contract ecosystem, leading the way toward mainstream Web3 adoption. It achieves this by innovating at every layer of the technology stack, including dApp development, infrastructure, consensus mechanisms, a comprehensive developer toolkit, and value accrual.
Read more on NIBI →